Clinical Reviews in Allergy & Immunology

, Volume 35, Issue 1–2, pp 72–78

Advances in the Treatments of Systemic Vasculitides


DOI: 10.1007/s12016-007-8068-4

Cite this article as:
Guillevin, L. Clinic Rev Allerg Immunol (2008) 35: 72. doi:10.1007/s12016-007-8068-4


Necrotizing systemic vasculitides are severe diseases in which prognosis improved since steroids and cytotoxic agents have been prescribed. The outcome is now better, and remission is obtained in more than 80% of patients. In this review paper, we will cover the indications of conventional treatments and new biotherapies and other therapies. The strategies that improve patient’s outcome are discussed in the light of the prospective trials organized by international research groups.


Advances Treatment Systemic vasculitides 

Copyright information

© Humana Press Inc. 2007

Authors and Affiliations

  1. 1.Service de Médecine Interne, Hôpital Cochin, Assistance Publique-Hôpitaux de ParisUniversité Paris René DescartesParisFrance

Personalised recommendations